Linearis Ventures

Feldan Therapeutics specializes in intracellular drug delivery using its patented Feldan Shuttle technology. This platform enables rapid, safe, and efficient transport of therapeutic agents into cells, with a focus on developing treatments for serious diseases such as skin and lung conditions.

Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By harnessing self-supervised learning and integrating diverse human multimodal data, the company aims to enhance the precision and effectiveness of immunotherapies. This approach enables the development of more personalized cancer treatments, contributing to the advancement of targeted therapies in oncology.

Zilia is a medical technology company that has developed a non-invasive platform using imaging, spectrometry, and artificial intelligence to quantitatively measure biomarkers in the human eye. Its initial product, Zilia Ocular, is a retinal camera designed to quantify oxygen saturation, a critical biomarker for ocular diseases like glaucoma, diabetic retinopathy, and age-related macular degeneration. The company aims to transform the prevention, diagnosis, and management of these diseases by providing actionable data on the eye's metabolic activity.